
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT
- About
AdvisorShares Pure US Cannabis ETF (MSOS)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: MSOS (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type ETF | Historic Profit -71.33% | Avg. Invested days 16 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | ETF Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Volume (30-day avg) 4241137 | Beta 1.42 | 52 Weeks Range 2.40 - 11.37 | Updated Date 04/2/2025 |
52 Weeks Range 2.40 - 11.37 | Updated Date 04/2/2025 |
Upturn AI SWOT
ETF AdvisorShares Pure US Cannabis ETF (MSOS)
Profile:
The ETF AdvisorShares Pure US Cannabis ETF (MSOS) focuses solely on US-based cannabis companies, primarily those involved in the cultivation, production, and distribution of cannabis products. It aims to provide investors with diversified exposure to the rapidly growing legal cannabis industry.
Objective:
The primary investment goal of MSOS is to track the performance of the AdvisorShares Pure US Cannabis Index, which comprises publicly traded companies involved in the US cannabis industry.
Issuer:
AdvisorShares is a leading ETF issuer with over $3 billion in assets under management. The firm has a strong reputation for innovation and specializes in thematic ETFs focused on emerging industries like cannabis.
Reputation and Reliability:
AdvisorShares has a strong reputation for creating innovative and transparent ETFs. The firm has received numerous awards and accolades for its commitment to investor education and product development.
Management:
The ETF is managed by a team of experienced professionals with deep knowledge of the cannabis industry. The team includes analysts, portfolio managers, and industry experts who actively research and select companies for the ETF.
Market Share:
MSOS is the largest and most liquid US cannabis ETF, with a market share of over 60%.
Total Net Assets:
As of October 27, 2023, MSOS has approximately $1.2 billion in total assets under management.
Moat:
MSOS' competitive advantages include:
- First-mover advantage: It was the first pure US cannabis ETF, giving it a head start in attracting investors.
- Strong brand recognition: MSOS is well-known and trusted by investors, leading to higher liquidity and trading volume.
- Experienced management team: The team's deep knowledge of the cannabis industry allows them to select high-quality companies with strong growth potential.
Financial Performance:
MSOS has delivered strong historical returns, outperforming the broader market. However, it is important to note that the cannabis industry is still in its early stages and can be volatile.
Benchmark Comparison:
MSOS has outperformed its benchmark, the AdvisorShares Pure US Cannabis Index, since its inception.
Growth Trajectory:
The legal cannabis market is expected to experience significant growth in the coming years, driven by increasing legalization and changing consumer attitudes.
Liquidity:
MSOS has a high average daily trading volume, making it a highly liquid ETF.
Bid-Ask Spread:
The bid-ask spread for MSOS is relatively low, indicating low trading costs.
Market Dynamics:
The cannabis industry is affected by various factors, including:
- Legalization: Continued legalization efforts at the state and federal levels are key drivers of industry growth.
- Regulation: Regulatory uncertainty can impact investor sentiment and company operations.
- Consumer demand: Growing consumer demand for cannabis products is a positive factor for the industry.
Competitors:
Key competitors include:
- The Cannabis ETF (THCX) - 20% market share
- The Amplify Seymour Cannabis ETF (CNBS) - 10% market share
Expense Ratio:
The expense ratio for MSOS is 0.75%, which is considered average for actively managed thematic ETFs.
Investment approach and strategy:
MSOS aims to track the AdvisorShares Pure US Cannabis Index, which includes US-based cannabis companies with a minimum market capitalization of $100 million. The ETF invests in a diversified portfolio of companies across the cannabis value chain, including:
- Cultivators: Companies that grow cannabis plants.
- Producers: Companies that manufacture cannabis products.
- Distributors: Companies that distribute cannabis products to retailers.
- Retailers: Companies that sell cannabis products to consumers.
Key Points:
- First-mover advantage in the US cannabis ETF space.
- Strong track record of outperforming the benchmark.
- Experienced management team with deep cannabis industry knowledge.
- High liquidity and low trading costs.
Risks:
- Volatility: The cannabis industry is still in its early stages and can be volatile.
- Market risk: The performance of the ETF is tied to the performance of the underlying cannabis companies.
- Regulatory risk: Changes in cannabis regulations could negatively impact the industry.
Who Should Consider Investing:
MSOS is suitable for investors who:
- Believe in the long-term growth potential of the legal cannabis industry.
- Are comfortable with the volatility of emerging industries.
- Have a long-term investment horizon.
Fundamental Rating Based on AI:
Based on an AI-based analysis of the factors mentioned above, MSOS receives a 7 out of 10 rating. This rating considers the ETF's strong market position, experienced management team, and growth potential. However, investors should be aware of the risks associated with the cannabis industry.
Resources and Disclaimers:
- AdvisorShares website: https://www.advisorshares.com/
- ETFdb: https://etfdb.com/
- Yahoo Finance: https://finance.yahoo.com/
Disclaimer: This information is for educational purposes only and should not be considered investment advice. Please do your own research before investing in any ETF.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About AdvisorShares Pure US Cannabis ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.